Stockreport

FDA accepts Motif Bio's NDA with priority review for Iclaprim [Seeking Alpha]

MOTIF BIO PLC ADRS  (MTFB) 
US:NASDAQ Investor Relations: ir.motifbio.com
PDF FDA accepts Motif Bio's NDA with priority review for Iclaprim [Read more]